SPX and Nasdaq hit new highs
Expectations that two Covid-19 vaccines could get emergency FDA approval, which would make up to 40 million doses available before the end of the year, had investors in a risk-on…
Read MoreExpectations that two Covid-19 vaccines could get emergency FDA approval, which would make up to 40 million doses available before the end of the year, had investors in a risk-on…
Read MoreThe Institute for Supply Management (ISM) reported its manufacturing index cooled to 57.5 for November
Read MoreThe environment is likely to stay volatile in both directions over coming days/weeks as we await the Georgia Senate runoff election. The S&P 500 (SPX) is very little changed from…
Read MoreStocks pulled back from last week’s record highs as investors looked to take some profits in the economic recovery areas of the market that have done so well in November.
Read MoreIt was a good week for equities, with the four major indices all setting record highs.
Read MoreS&P equity futures remain below Friday's close, amidst a mostly lower session in Europe and Asian shares ending in negative territory overnight.
Read MoreJust a month ago very few could imagine how the market could go up as the S&P 500 (SPX) was down roughly 8% in the last two weeks of October…
Read MoreWith the market moving up to new highs, retail investors became more bullish and more bearish on future market direction in the latest survey.
Read MoreUS equity futures are a bit higher in Friday morning trading ahead of a shortened day of trading, with the major indexes on pace for a week of solid gains.…
Read More